| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Prelude Therapeutics Incorporated (PRLD) has 6 insiders with recent SEC Form 4 filings, including 4 buys and 19 sells. PRLD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 11.81M | $51.01M | - | |
| 10% | 6.48M | $27.98M | - | |
| 10% | 1.13M | $4.86M | - | |
| Dir | 121.3K | $524.0K | - | |
| Pres | 86.9K | $375.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 8, 2022 | Chardonnet Laurent45 | Chief Financial Officer | Buy | 10,000 | $4.76 | $47,600.00 | +38.7% | +19.2% | -33.6% | |
| Jun 1, 2022 | Chardonnet Laurent45 | Chief Financial Officer | Buy | 10,000 | $4.23 | $42,300.00 | +69.0% | +69.1% | +32.1% | |
| Dec 15, 2021 | Morosini Deborah82 | EVP, Chief Of Clinical Affairs | Sale+OE | 28,751 | $13.00 | $373,763.00 | -98.5% | -46.2% | -60.9% | |
| Dec 14, 2021 | Combs Andrew56 | EVP, Head Of Chemistry | Buy | 8,000 | $11.86 | $94,880.00 | +1.5% | -34.8% | -56.3% | |
| Nov 16, 2021 | Morosini Deborah82 | EVP, Chief Of Clinical Affairs | Sale+OE | 28,751 | $15.88 | $456,531.56 | -95.7% | -39.0% | -51.9% | |
| Oct 5, 2021 | Mauro David J90 | Chief Medical Officer | Sale+OE | 15,000 | $30.96 | $464,349.91 | -59.1% | -56.0% | -76.3% | |
| Sep 7, 2021 | Mauro David J90 | Chief Medical Officer | Sale+OE | 15,000 | $36.69 | $550,282.55 | -55.2% | -63.4% | -80.0% | |
| Sep 2, 2021 | Pierce Christopher82 | EVP And Chief Of Business Oper | Sale+OE | 17,000 | $41.68 | $708,492.70 | -34.8% | -64.4% | -80.2% | |
| Aug 27, 2021 | Scherle Peggy88 | Chief Scientific Officer | Sale+OE | 7,714 | $35.75 | $275,786.75 | -1.1% | -62.7% | -79.3% | |
| Aug 25, 2021 | Piper Brian | Chief Financial Officer | Sale+OE | 8,333 | $33.34 | $277,827.45 | -49.3% | -58.4% | -76.0% |